US › Healthcare

Silo Pharma Inc (SILO)

US · Healthcare · Biotechnology

$4.60+6.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$18,026
Revenue YoY
0.0%
Net profit
$-1.6M
Profit YoY
-59.7%
EPS
$-1.80
Net margin
-9,137.5%

Key statistics

Market cap
$4.7M
Forward P/E
0.0
P/B
0.83
Book value
$5.24
EPS (TTM)
$-5.85
52-week high
$15.15
52-week low
$3.31
50-day MA
$5.68
200-day MA
$6.04
Beta
0.75

Analyst view

Analysts rate Silo Pharma Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders
16.41%
Institutions
11.13%

Largest institutional holders

FundStake
AdvisorShares Investments, LLC4.99%
Geode Capital Management, LLC1.35%
Susquehanna International Group, LLP0.47%
Jane Street Group LLC0.34%
Vanguard Group Inc0.18%
Citadel Advisors Llc0.16%
XTX Topco Ltd0.13%
TWO SIGMA SECURITIES, LLC0.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Silo Pharma Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.